PharmTech

Metformin HCl Extended Release Tablets Recalled

Nostrum Laboratories is recalling Metformin HCl Extended Release Tablets because of NDMA above the acceptable daily intake limit. Nostrum Laboratories (Kansas City, MO) announced on Nov. 2, 2020 that ...
clinicaladvisor.com

Twice-daily tablet to control blood sugar

Active ingredients: Linagliptin, metformin HCl; 2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1,000 mg; tablets. Indication: Adjunct to diet and exercise in type 2 diabetes when treatment with both linagliptin ...
PharmTech

Nostrum Laboratories Expands Recall of Metformin HCl Extended Release Tablets

The company is recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) because of nitrosamine impurities. Nostrum Laboratories, Inc.
FierceBiotech

KOMBIGLYZE™ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabetes Mellitu

PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE ™ XR (saxagliptin and metformin HCl extended-release), ...
WSB-TV

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N ...

Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and ...
FierceBiotech

KOMBIGLYZE™ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 D | Fierce Biotech

PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...
EurekAlert!

ACTOplus met™ (pioglitazone HCl and metformin HCl)

LINCOLNSHIRE, Ill., November 1, 2005 – Takeda Pharmaceuticals North America, Inc. today announced that ACTOplus met TM (pioglitazone HCl and metformin HCl) is now available by prescription in ...
Business Wire

Dr. Reddy's Laboratories Announces its Launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today ...
The Financial Express

Dr. Reddy’s Laboratories launches Saxagliptin and Metformin Hydrochloride tablets

Dr. Reddy’s Laboratories Ltd. on Thursday announced its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S. market. It is the generic version of KOMBIGLYZE XR ...
USA Today

Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level. View full recall details at FDA.gov Recalled dog ...
FiercePharma

KOMBIGLYZE™ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 D

PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...